We are live on ! Find out more
RCMNY

Rubric Capital Management (New York) Portfolio holdings

AUM $9.44B
1-Year Est. Return 68.42%
This Fund
S&P 500
This Quarter Est. Return
+25.86%
1 Year Est. Return
+68.42%
3 Year Est. Return
+212.09%
5 Year Est. Return
+270.59%
10 Year Est. Return
–
AUM
$8.86B
AUM Growth
+$2.24B
Cap. Flow
+$911M
Cap. Flow %
10.28%
Top 10 Hldgs %
59.7%
Holding
84
New
18
Increased
19
Reduced
9
Closed
12

Top Buys

Rank Stock Value
1
BAX icon
Baxter International
BAX
+$95.7M
2
ENOV icon
Enovis
ENOV
+$83.4M
3
LILAK icon
Liberty Latin America Class C
LILAK
+$77M
4
NWL icon
Newell Brands
NWL
+$73.7M
5
EOSE icon
Eos Energy Enterprises
EOSE
+$70.5M

Top Sells

Rank Stock Value
1
TLN
Talen Energy Corp
TLN
+$326M
2
VST icon
Vistra
VST
+$276M
3
INDV icon
Indivior Pharmaceuticals
INDV
+$73.6M
4
ADPT icon
Adaptive Biotechnologies
ADPT
+$72.9M
5
COOP
Mr. Cooper
COOP
+$50.4M

Sector Composition

Rank Sector Weight
1 Healthcare 31.07%
2 Utilities 21%
3 Industrials 12.9%
4 Energy 5.78%
5 Financials 3.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SUPN icon
51
Supernus Pharmaceuticals
SUPN
$2.78B
$28.5M 0.32%
595,366
-99,673
-14% -$4.01M
INDV icon
52
Indivior Pharmaceuticals
INDV
$4.57B
$27.3M 0.31%
1,130,961
-3,516,218
-76% -$73.6M
ACHC icon
53
Acadia Healthcare
ACHC
$2.95B
$27.2M 0.31%
+1,100,000
New +$24.5M
XPER icon
54
Xperi
XPER
$321M
$26.9M 0.3%
4,143,744
– –
TTI icon
55
TETRA Technologies
TTI
$1.29B
$26M 0.29%
+4,529,783
New +$19.3M
CNNE icon
56
Cannae Holdings
CNNE
$651M
$24.2M 0.27%
1,319,589
-786,275
-37% -$15.5M
DAWN
57
DELISTED
Day One Biopharmaceuticals
DAWN
$23.8M 0.27%
+3,377,071
New +$23.2M
TSAT icon
58
Telesat
TSAT
$934M
$22.4M 0.25%
843,781
– –
TH icon
59
Target Hospitality
TH
$1.61B
$18.6M 0.21%
2,189,456
– –
BG icon
60
Bunge Global
BG
$21.5B
$15.3M 0.17%
+188,347
New +$15.1M
PRTA icon
61
Prothena Corp
PRTA
$475M
$15M 0.17%
+1,540,373
New +$11.8M
EMBC icon
62
Embecta
EMBC
$269M
$14.6M 0.17%
1,037,416
– –
LILA icon
63
Liberty Latin America Class A
LILA
$1.69B
$14.5M 0.16%
+2,565,792
New +$12.8M
SEG
64
Seaport Entertainment Group
SEG
$373M
$13M 0.15%
568,530
– –
MHK icon
65
Mohawk Industries
MHK
$9.27B
$11.1M 0.12%
+85,726
New +$10.6M
ABUS icon
66
Arbutus Biopharma
ABUS
$907M
$7.15M 0.08%
1,575,376
– –
GIL icon
67
Gildan
GIL
$10.6B
$4.87M 0.05%
+84,252
New +$4.51M
MYPS icon
68
PLAYSTUDIOS Inc
MYPS
$72.1M
$2.6M 0.03%
2,697,384
– –
EDSA icon
69
Edesa Biotech
EDSA
$51.1M
$1.7M 0.02%
687,500
– –
THS
70
DELISTED
Treehouse Foods
THS
$1.42M 0.02%
+70,372
New +$1.33M
TXMD icon
71
TherapeuticsMD
TXMD
$24.1M
$1.28M 0.01%
1,192,191
– –
ADPT icon
72
Adaptive Biotechnologies
ADPT
$4.02B
– –
-6,256,847
Closed -$72.9M
CEG icon
73
Constellation Energy
CEG
$98.7B
– –
-54,507
Closed -$17.6M
CHRS icon
74
Coherus Oncology
CHRS
$181M
– –
-867,800
Closed -$635K
COOP
75
DELISTED
Mr. Cooper
COOP
– –
-337,924
Closed -$50.4M
1 2
3
4

Similar funds

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SIM
SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return
NPT
National Philanthropic Trust Jenkintown, Pennsylvania $9.38B AUM 33.37% 1-Year Est. Return
AC
Allstate Corporation Northbrook, Illinois $9.35B AUM 16.13% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.34B AUM 12.2% 1-Year Est. Return
WPL
WINDACRE PARTNERSHIP LLC Houston, Texas $9.34B AUM 17.41% 1-Year Est. Return
LAMI
Longview Asset Management (Illinois) Chicago, Illinois $9.56B AUM 25.94% 1-Year Est. Return
CCMT
CMT Capital Markets Trading Frankfurt, Germany $9.56B AUM 21.2% 1-Year Est. Return

Rubric Capital Management (New York)'s Q3 2025 Portfolio in Review

As of Q3 2025, Rubric Capital Management (New York) held 84 positions worth $8.86B, up 34% from $6.62B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

Rubric Capital Management (New York) deployed $911M of net new capital in Q3 2025, opening 18 new positions and adding to 19 existing holdings. Its largest new stake was Baxter International: 3,774,889 shares worth $86M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, down from 32% a quarter earlier, followed by Utilities and Industrials.

On the sell side, the largest reduction was Talen Energy Corp, an estimated $326M trimmed.

  • Rubric Capital Management (New York)'s largest Q3 2025 buy was Baxter International: 3,774,889 shares worth $86M.
  • Rubric Capital Management (New York) added most to Ecovyst in Q3 2025, an estimated $50.2M increase.
  • Rubric Capital Management (New York)'s biggest Q3 2025 reduction was Talen Energy Corp, cutting an estimated $326M.
  • Rubric Capital Management (New York) fully exited Vistra in Q3 2025, selling an estimated $276M.
  • Rubric Capital Management (New York)'s ten largest holdings make up 60% of its $8.86B portfolio in Q3 2025.
  • Rubric Capital Management (New York) opened 18 new positions and closed 12 in Q3 2025.
  • Rubric Capital Management (New York)'s portfolio value rose 34% quarter-over-quarter to $8.86B.

Based on Rubric Capital Management (New York)'s 13F filing for Q3 2025, filed 14 Nov 2025.